Articles tagged with Parasites
Researchers have discovered that a sugar in mosquitoes allows the malaria-causing parasite to attach itself to the gut, enabling its development and transmission. Reducing this sugar can prevent parasites from developing, offering a promising approach to blocking malaria spread.
Researchers found that the human immune system uses hemoglobin to bind to HDL and create a toxin that clears trypanosomes from the body. This discovery could lead to better treatment options for cattle infections and provide insights into understanding why some parasites don't infect humans.
Binghamton University researchers study archived human blood samples to understand how Plasmodium falciparum evolved resistance to chloroquine. The analysis aims to provide insights for current treatments and future drug development.
Researchers discovered that heparan sulfate is a receptor for the malaria parasite, allowing it quick transport through the body. This finding could lead to an environmentally safe and inexpensive way to block infection in mosquitoes, preventing malaria spread without drug side effects.
A new study found that repeated ivermectin treatment selects for genetic changes in the parasite that cause river blindness, potentially leading to drug resistance. The research has implications for ongoing onchocerciasis control programs.
A study by University of Alaska Fairbanks researcher Hector Douglas found that crested auklets use chemical anointment during courtship to protect themselves from parasites like ticks. The birds rub their wick feathers with a citrus-like scent, which repels ticks and helps keep them healthy.
Scientists have identified a key mechanism in the malaria parasite that allows it to adapt to infected individuals by switching on and off protein expression. The study reveals that 7 genes can be silenced without compromising the parasite's ability to enter red blood cells.
Researchers at UT Southwestern Medical Center have discovered why some mosquitoes are resistant to malaria, focusing on a protein called TEP1. The study found that genetic differences in TEP1 manifest in a region dubbed the 'warhead', which grabs onto malarial parasites.
A study found that drug resistance in the Onchocerca volvulus parasite, which causes river blindness, is emerging and could lead to a resurgence of the disease. Despite ivermectin treatment clearing most microfilariae, four communities showed significant repopulation of skin with microfilariae, allowing transmission of the disease.
An international team of researchers led by MIT Professor Subra Suresh has demonstrated that the parasite protein RESA causes red blood cells to become less deformable, a hallmark of deadly malaria. The study's findings could lead to treatments targeting this protein.
Research reveals that parasites can significantly alter the abundance of edible algae, which is a crucial resource for various organisms. This finding suggests that non-lethal impacts of parasites can have far-reaching effects on entire ecosystems.
Researchers have determined the atomic structure of a key protein that helps toxoplasmosis parasites invade human cells. The protein binds to specific sugars on host cell surfaces, allowing the parasite to stick and enter cells.
Researchers at Johns Hopkins University have developed a new series of potent synthetic drugs modeled on an ancient Chinese herbal folk remedy that cure malaria-infected mice with a single shot. The compounds, containing a crucial oxygen-oxygen unit, promise to be more effective and potentially safer than current treatments.
Dutch researcher Mike van der Kolk discovered that people who are frequently infected with malaria parasites can develop immunity against the gametocyte, inhibiting the spread of the parasite. This natural immunity prevents the parasite from reproducing in mosquitoes, ultimately stopping its transmission.
Researchers have identified a novel pathway in Trypanosoma brucei parasites that can be triggered to shut down the synthesis of a crucial RNA molecule, leading to parasite death. This discovery has implications for eradicating other parasitic diseases such as Leishmania and Chagas disease.
A new study found that the most commonly used malaria vaccine may not be effective against the prevalent strain in Mali. The researchers discovered that only 16% of infections were caused by the strain included in the vaccine, highlighting the importance of testing vaccines in diverse populations.
A University of Florida study reveals that humans acquired pubic lice from gorillas around 3.3 million years ago, providing insights into human evolution and the history of parasites. The research suggests that lice can be transmitted through non-sexual means, such as sleeping in close proximity or feeding on prey.
A novel form of trypanosomiasis has been identified in India, resulting from a deficiency in apolipoprotein L-1. Analysis revealed that the patient's serum lacked the protein's trypanolytic activity, which normally destroys parasites.
Researchers discovered the first human case of insect-transmitted Chagas parasite in Louisiana, with over half of collected insects carrying the parasite. The finding, while significant, does not represent a widespread public health concern due to limited rural housing conditions.
Researchers discover how malaria parasites hijack red blood cells and develop a new strategy to block them using propranolol. The finding opens the possibility for important new drugs that won't become resistant, addressing the growing problem of drug-resistant malaria.
The scientists' achievement provides new avenues for diagnosing and treating this sexually transmitted disease, affecting an estimated 170 million people worldwide. The genome contains genes and proteins not found in humans, which can help expand drug options and devise a diagnostic test.
Researchers discovered a single Toxoplasma protein, ROP16, that travels to the host cell nucleus and blocks normal responses to invasion. This finding has wide-ranging implications for diseases caused by other parasites, including malaria.
Recent studies published in major scientific journals reveal the molecular mechanisms behind Toxoplasma gondii's severity and its link to AIDS patients' dementia. The research provides a model for studying toxoplasmosis and related diseases, with potential applications for developing more effective treatments.
A comprehensive genetic analysis of an invasive marine host and its parasites reveals the accidental introduction of Japanese seed oysters carrying parasitic flatworms, leading to widespread disease in the region. The study highlights the importance of identifying and mitigating disease outbreaks in a globalized economy.
Researchers developed a malaria vaccine that prompts the immune system to eliminate the parasite from an area's mosquitoes. The vaccine was tested in mice and showed promise by eliminating the parasite from the digestive tract of infected mosquitoes.
Researchers found that snail hosts arriving from Japan led to novel disease outbreaks in North America. Genetic analysis revealed distinct invasion pathways for two cryptic species of trematode parasites, one arriving with the snails and the other historically dispersed by migratory birds.
Researchers at Stanford University School of Medicine have identified two proteins, ROP16 and ROP18, that are critical to Toxoplasma's ability to infect and reproduce inside human cells. The study found that changes in these proteins can ramp up damage to the host by 10,000-fold.
A single gene, ROP18, accounts for 90% of Toxoplasma gondii's virulence, making it a key target for identifying and treating the parasite's most dangerous strains. Researchers hope to develop new treatments using existing kinase inhibitors.
A genome-scale map of genetic variation in the malaria parasite has been completed, revealing nearly 47,000 specific genetic differences among parasites worldwide. This study provides a critical foundation for dissecting the functions of important parasite genes and tracing the global spread of malaria.
A massive effort to sequence and compare complete or partial genomes of Plasmodium falciparum has revealed nearly 47,000 genetic variations. This data will help researchers understand the parasite's evolution and study malarial drug resistance. New antigens identified may be potential targets for new therapeutics or vaccines.
A new study provides a reliable way to diagnose cerebral malaria in children through changes to the retina. This discovery could greatly reduce child mortality rates from this major childhood killer.
A CU-Boulder research team has discovered over 200 suspected parasite burrows in a well-preserved duck-billed dinosaur, indicating the presence of tiny worms similar to annelids and nematodes. The findings provide evidence for interactions between dinosaurs and invertebrates.
Research by S. Kankova and colleagues found that Toxoplasma positive mothers give birth to more boys than negative women, with a probability of up to 72 boys in every 100 children born. The increased survival of male embryos may be attributed to the parasite's modulating effects on the immune system.
Researchers discovered that parasitic plants like Cuscuta pentagona sense and respond to volatile chemicals emitted by potential host plants. They found that dodder seedlings grew towards tomato plants in a specific direction, indicating a directed growth response.
Researchers at Karolinska Institutet in Sweden and Makerere University in Uganda have identified how the malaria parasite conceals itself in the placenta, paving the way for a potential vaccine. The study found that several receptors on the placenta are involved in binding to the parasite, contrary to previous laboratory studies.
Scientists at Johns Hopkins have identified a previously unknown way the trypanosome parasite that causes African sleeping sickness makes fatty acids. The discovery of this unique biochemical pathway could lead to the development of new drugs to treat the illness.
Chagas' disease kills 50,000 people annually, with 18 million already infected and 100 million at risk. The disease has no initial symptoms, expensive prevention methods, and limited treatment options, prompting The Lancet to call for increased research attention.
A research team at the University of Georgia has identified a crucial metabolic pathway in Toxoplasma gondii that is essential for its survival. This discovery could lead to the development of new drugs to control the parasite's effects on humans and animals, particularly pregnant mothers and those with compromised immune systems.
Researchers used real-time imaging to track malaria infections in live mice, discovering that the parasite uses dead liver cells to cloak and transport itself back into the bloodstream. The study provides insights into the parasite's complex life cycle and potential ways to treat malaria.
Researchers suggest that Toxoplasma gondii, a common cat parasite, may influence human behavior and cultural aspects such as ego, money, and work. High prevalence of the parasite in certain regions is associated with higher neuroticism scores and differences in masculine sex roles.
Researchers found that parasites dominated the links between species in food webs, with a significant impact on ecosystem stability. The study also revealed new patterns, including increased vulnerability of mid-trophic level animals to parasites and predators.
A study by Ohio State University researchers found that mice lacking a specific gene produce fewer parasites in their livers, preventing the disease from developing. This discovery may lead to the creation of new drugs to treat different diseases affecting the liver.
A recent study by Scripps Research Institute has identified novel immunogens and genes involved in the development of drug resistance, which could lead to new vaccine targets. The research uses gene-chip technology to analyze the genomes of Plasmodium falciparum parasites.
Researchers examined the mosquito immune system and found that it employs similar factors to defend against different Plasmodium species. Boosting the mosquito's capacity to fight malaria parasites could be achieved through exposure to certain microbes or compounds.
Researchers are using California horn snails as a 'data logger' to monitor trematode populations and infer predator-prey relationships in wetland ecosystems. The study found that higher parasite counts were associated with more bird species, indicating the effectiveness of this method for assessing biodiversity.
Researchers discovered a new function for glycolipids in responding to cell stress, which may lead to treatment development for diseases like human African trypanosomiasis. The study also uncovered a pathway for protein movement in trypanosomes that could be relevant to human cells.
Researchers at VIB have made a significant breakthrough in combating African sleeping sickness by developing a nanobody that carries an ApoL-1 variant to the surface of the parasite. This treatment has shown promising results in mice, with infected animals surviving after a single treatment and the parasite being removed from their blood.
Researchers have discovered the structure of Anopheles gambiae's 3-hydroxykynurenine transaminase, a key enzyme in its oxidative defense mechanism. This finding could lead to the development of novel antimalarial agents by inhibiting this enzyme and disrupting the malaria parasite's lifecycle.
Mass drug administration has led to sharp falls in infection rates and transmission in both study areas. The Egyptian national programme is likely to be successful if sentinel villages are representative of communities included in the programme.
After five years of mass treatments, rates of filarial infection have sharply declined in Egypt. The Egyptian campaign to eliminate these infections has achieved its goals in most areas, with the parasite's transmission efficiency being low enough for remaining infections to die out on their own.
Human activities are disrupting the balance of diseases in oceans, causing harm to sea lions, marine mammals, and humans. Coral diseases, linked to sugars from sewage and run-off, are also on the rise, threatening coral reefs.
Researchers used mathematical modeling tools to document the spread of sea lice from commercial salmon farms to wild Pacific salmon. The study found that a single farm could lead to a massive increase in parasite load, affecting the health of young fish.
Scientists from five institutions identify five vaccine targets for an East Coast fever subunit vaccine, which triggered a strong immune response in lab tests. The researchers used the genome sequence of the parasite responsible for the disease to develop the vaccine.
Researchers found that up to 25% of injected malaria parasites stop in lymph nodes close to the bite site, where they can interact with immune cells and degrade. While partially developed or destroyed parasites may not contribute to symptoms, their presence could affect how the immune system responds to infection.
Scientists have identified the DNA sequence controlling the malaria parasite's ability to change its disguises, a key virulence factor. This breakthrough could lead to the design of a drug candidate molecule that freezes the parasite's disguise capability, allowing the human immune system to respond effectively.
Researchers at Howard Hughes Medical Institute have determined how P. falciparum parasites can turn on one cloaking gene and keep dozens of others silent until needed. This discovery reveals the mechanism behind the parasite's survival and has implications for developing new therapies to interfere with its immune evasion strategies.
Researchers have discovered a unique architecture of the Duffy-Binding Like (DBL) domain that allows the malaria parasite to bind to red blood cells. This finding may lead to the development of specific drugs that can target the parasite without affecting healthy blood cells.
A team of researchers has discovered a parasite enzyme, PfSUB2, that sheds sticky surface proteins, allowing the parasite to invade red blood cells. The discovery could lead to the development of new antimalarial drugs that target this enzyme.
New study in Cameroon confirms declining effectiveness of malaria drugs like sulfadoxine-pyrimethamine and amodiaquine, highlighting need for alternative treatments. Researchers highlight importance of monitoring resistance and patient adherence to effective treatment regimens.
Researchers discovered that two proteins in HDLs work synergistically to kill the Nagana parasite in humans. This finding contradicts a long-held hypothesis and provides new information for treatments of parasitic infections like malaria.